TNF-R1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TNF-R1 monoclonal antibodies for research focused on tumor necrosis factor receptor 1 (TNF-R1) in various biological processes. TNF-R1 monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TNF-R1 is a crucial receptor that mediates the effects of tumor necrosis factor-alpha (TNF-α), a key cytokine in inflammation and immune response. TNF-R1 signaling pathways influence cell proliferation, differentiation, and apoptosis, making TNF-R1 an important target for studying various diseases, including autoimmune disorders and cancer. Research into TNF-R1 signaling pathways continues to reveal potential therapeutic strategies for modulating immune responses. Investigating TNF-R1 function has led to significant breakthroughs in understanding inflammatory diseases and cancer biology. Advanced research techniques have revealed complex mechanisms of TNF-R1-mediated cellular responses. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TNF-R1's role in health and disease.